nodes	percent_of_prediction	percent_of_DWPC	metapath
Debrisoquin—CYP2D6—Parkinson's disease	0.526	0.583	CbGaD
Debrisoquin—ABCB1—Parkinson's disease	0.376	0.417	CbGaD
Debrisoquin—SLC6A2—locus ceruleus—Parkinson's disease	0.0124	0.237	CbGeAlD
Debrisoquin—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00982	0.188	CbGeAlD
Debrisoquin—SLC6A2—autonomic nervous system—Parkinson's disease	0.0066	0.126	CbGeAlD
Debrisoquin—SLC6A2—nerve—Parkinson's disease	0.00371	0.071	CbGeAlD
Debrisoquin—SLC6A2—Monoamine Transport—DBH—Parkinson's disease	0.00195	0.0428	CbGpPWpGaD
Debrisoquin—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.00184	0.0405	CbGpPWpGaD
Debrisoquin—SLC6A2—brainstem—Parkinson's disease	0.00159	0.0305	CbGeAlD
Debrisoquin—SLC6A2—forebrain—Parkinson's disease	0.00154	0.0294	CbGeAlD
Debrisoquin—CYP2D6—hindbrain—Parkinson's disease	0.00152	0.0291	CbGeAlD
Debrisoquin—SLC6A2—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.00128	0.0281	CbGpPWpGaD
Debrisoquin—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Parkinson's disease	0.00121	0.0266	CbGpPWpGaD
Debrisoquin—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00119	0.0262	CbGpPWpGaD
Debrisoquin—SLC6A2—medulla oblongata—Parkinson's disease	0.00111	0.0212	CbGeAlD
Debrisoquin—SLC6A2—Monoamine Transport—ADORA2A—Parkinson's disease	0.00107	0.0235	CbGpPWpGaD
Debrisoquin—SLC6A2—head—Parkinson's disease	0.000881	0.0168	CbGeAlD
Debrisoquin—CYP2D6—brainstem—Parkinson's disease	0.000873	0.0167	CbGeAlD
Debrisoquin—CYP1A1—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000858	0.0189	CbGpPWpGaD
Debrisoquin—CYP2D6—forebrain—Parkinson's disease	0.000842	0.0161	CbGeAlD
Debrisoquin—SLC6A2—Amine compound SLC transporters—SLC6A3—Parkinson's disease	0.000839	0.0184	CbGpPWpGaD
Debrisoquin—SLC6A2—nervous system—Parkinson's disease	0.000835	0.016	CbGeAlD
Debrisoquin—SLC6A2—central nervous system—Parkinson's disease	0.000804	0.0154	CbGeAlD
Debrisoquin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000803	0.0177	CbGpPWpGaD
Debrisoquin—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000797	0.0175	CbGpPWpGaD
Debrisoquin—SLC6A2—Monoamine Transport—TH—Parkinson's disease	0.000797	0.0175	CbGpPWpGaD
Debrisoquin—SLC6A2—Monoamine Transport—SLC6A3—Parkinson's disease	0.000797	0.0175	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000785	0.0173	CbGpPWpGaD
Debrisoquin—CYP1A1—Xenobiotics—CYP2D6—Parkinson's disease	0.000718	0.0158	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen metabolism—NQO1—Parkinson's disease	0.000706	0.0155	CbGpPWpGaD
Debrisoquin—CYP1A1—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00069	0.0152	CbGpPWpGaD
Debrisoquin—ABCB1—embryo—Parkinson's disease	0.000685	0.0131	CbGeAlD
Debrisoquin—CYP1A1—head—Parkinson's disease	0.000668	0.0128	CbGeAlD
Debrisoquin—CYP1A1—Xenobiotics—CYP2E1—Parkinson's disease	0.000656	0.0144	CbGpPWpGaD
Debrisoquin—SLC6A2—brain—Parkinson's disease	0.000638	0.0122	CbGeAlD
Debrisoquin—CYP1A1—nervous system—Parkinson's disease	0.000633	0.0121	CbGeAlD
Debrisoquin—CYP1A1—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000631	0.0139	CbGpPWpGaD
Debrisoquin—CYP1A1—central nervous system—Parkinson's disease	0.00061	0.0117	CbGeAlD
Debrisoquin—ABCB1—forebrain—Parkinson's disease	0.000606	0.0116	CbGeAlD
Debrisoquin—CYP1A1—Estrogen metabolism—COMT—Parkinson's disease	0.000592	0.013	CbGpPWpGaD
Debrisoquin—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000591	0.013	CbGpPWpGaD
Debrisoquin—CYP1A1—Tryptophan metabolism—DDC—Parkinson's disease	0.000589	0.013	CbGpPWpGaD
Debrisoquin—CYP1A1—Estrogen metabolism—GSTM1—Parkinson's disease	0.000541	0.0119	CbGpPWpGaD
Debrisoquin—CYP1A1—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000533	0.0117	CbGpPWpGaD
Debrisoquin—ABCB1—cardiovascular system—Parkinson's disease	0.000512	0.00979	CbGeAlD
Debrisoquin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.0005	0.011	CbGpPWpGaD
Debrisoquin—CYP1A1—Tryptophan metabolism—MAOB—Parkinson's disease	0.000496	0.0109	CbGpPWpGaD
Debrisoquin—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000494	0.0109	CbGpPWpGaD
Debrisoquin—CYP1A1—brain—Parkinson's disease	0.000484	0.00925	CbGeAlD
Debrisoquin—CYP2D6—head—Parkinson's disease	0.000482	0.00922	CbGeAlD
Debrisoquin—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000475	0.0104	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—NQO1—Parkinson's disease	0.000469	0.0103	CbGpPWpGaD
Debrisoquin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00046	0.0101	CbGpPWpGaD
Debrisoquin—CYP2D6—nervous system—Parkinson's disease	0.000457	0.00874	CbGeAlD
Debrisoquin—CYP2D6—central nervous system—Parkinson's disease	0.00044	0.00841	CbGeAlD
Debrisoquin—ABCB1—medulla oblongata—Parkinson's disease	0.000438	0.00837	CbGeAlD
Debrisoquin—CYP2D6—cerebellum—Parkinson's disease	0.00043	0.00822	CbGeAlD
Debrisoquin—CYP1A1—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000401	0.00882	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—SOD1—Parkinson's disease	0.000401	0.00882	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—GSTA4—Parkinson's disease	0.000401	0.00881	CbGpPWpGaD
Debrisoquin—ABCB1—midbrain—Parkinson's disease	0.0004	0.00765	CbGeAlD
Debrisoquin—CYP1A1—Oxidative Stress—MAOA—Parkinson's disease	0.00039	0.00859	CbGpPWpGaD
Debrisoquin—ABCB1—spinal cord—Parkinson's disease	0.00039	0.00746	CbGeAlD
Debrisoquin—CYP1A1—Oxidative Stress—HMOX1—Parkinson's disease	0.000386	0.00849	CbGpPWpGaD
Debrisoquin—CYP1A1—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000374	0.00822	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000371	0.00815	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidative Stress—SOD2—Parkinson's disease	0.000361	0.00794	CbGpPWpGaD
Debrisoquin—CYP2D6—brain—Parkinson's disease	0.000349	0.00668	CbGeAlD
Debrisoquin—ABCB1—head—Parkinson's disease	0.000347	0.00663	CbGeAlD
Debrisoquin—CYP1A1—Oxidative Stress—GPX1—Parkinson's disease	0.000344	0.00757	CbGpPWpGaD
Debrisoquin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000343	0.00754	CbGpPWpGaD
Debrisoquin—CYP1A1—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000337	0.00741	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.000333	0.00733	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.000333	0.00733	CbGpPWpGaD
Debrisoquin—ABCB1—nervous system—Parkinson's disease	0.000329	0.00629	CbGeAlD
Debrisoquin—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000328	0.00721	CbGpPWpGaD
Debrisoquin—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000325	0.00715	CbGpPWpGaD
Debrisoquin—SLC6A2—Monoamine Transport—IL1B—Parkinson's disease	0.000325	0.00715	CbGpPWpGaD
Debrisoquin—ABCB1—central nervous system—Parkinson's disease	0.000317	0.00605	CbGeAlD
Debrisoquin—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000315	0.00693	CbGpPWpGaD
Debrisoquin—ABCB1—cerebellum—Parkinson's disease	0.00031	0.00591	CbGeAlD
Debrisoquin—CYP1A1—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000304	0.00669	CbGpPWpGaD
Debrisoquin—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000302	0.00664	CbGpPWpGaD
Debrisoquin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000298	0.00655	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000296	0.00652	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000294	0.00647	CbGpPWpGaD
Debrisoquin—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000281	0.00619	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000276	0.00607	CbGpPWpGaD
Debrisoquin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000273	0.00599	CbGpPWpGaD
Debrisoquin—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000269	0.00591	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000262	0.00577	CbGpPWpGaD
Debrisoquin—ABCB1—brain—Parkinson's disease	0.000251	0.0048	CbGeAlD
Debrisoquin—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000245	0.00538	CbGpPWpGaD
Debrisoquin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000242	0.00531	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—NQO1—Parkinson's disease	0.00024	0.00528	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—HSPA1A—Parkinson's disease	0.000238	0.00524	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—SLC6A3—Parkinson's disease	0.000237	0.0052	CbGpPWpGaD
Debrisoquin—SLC6A2—Monoamine Transport—TNF—Parkinson's disease	0.000236	0.00518	CbGpPWpGaD
Debrisoquin—CYP1A1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000229	0.00503	CbGpPWpGaD
Debrisoquin—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000229	0.00503	CbGpPWpGaD
Debrisoquin—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.000227	0.005	CbGpPWpGaD
Debrisoquin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000221	0.00486	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000218	0.00479	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000218	0.00479	CbGpPWpGaD
Debrisoquin—SLC6A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000209	0.0046	CbGpPWpGaD
Debrisoquin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000206	0.00454	CbGpPWpGaD
Debrisoquin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000205	0.00451	CbGpPWpGaD
Debrisoquin—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000202	0.00445	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—GSTP1—Parkinson's disease	0.0002	0.0044	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—HMOX1—Parkinson's disease	0.000197	0.00434	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTA4—Parkinson's disease	0.000194	0.00426	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000191	0.0042	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—GSTM1—Parkinson's disease	0.000184	0.00404	CbGpPWpGaD
Debrisoquin—SLC6A2—NRF2 pathway—HGF—Parkinson's disease	0.000184	0.00404	CbGpPWpGaD
Debrisoquin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000182	0.004	CbGpPWpGaD
Debrisoquin—CYP1A1—PPARA activates gene expression—CTGF—Parkinson's disease	0.00018	0.00396	CbGpPWpGaD
Debrisoquin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—Parkinson's disease	0.000176	0.00388	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—MAOB—Parkinson's disease	0.000173	0.0038	CbGpPWpGaD
Debrisoquin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000166	0.00366	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000164	0.00361	CbGpPWpGaD
Debrisoquin—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000155	0.0034	CbGpPWpGaD
Debrisoquin—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000149	0.00328	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000146	0.00321	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000144	0.00316	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000139	0.00305	CbGpPWpGaD
Debrisoquin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000137	0.00301	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000134	0.00295	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.00013	0.00286	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000128	0.00282	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000127	0.00278	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.000123	0.00271	CbGpPWpGaD
Debrisoquin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.000121	0.00267	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000117	0.00258	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000116	0.00255	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000116	0.00254	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000115	0.00253	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000107	0.00236	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000106	0.00234	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—COMT—Parkinson's disease	9.73e-05	0.00214	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	9.72e-05	0.00214	CbGpPWpGaD
Debrisoquin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	9.72e-05	0.00214	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	9.68e-05	0.00213	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	9.66e-05	0.00212	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	9.59e-05	0.00211	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	9.59e-05	0.00211	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	9.59e-05	0.00211	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	9.55e-05	0.0021	CbGpPWpGaD
Debrisoquin—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	8.9e-05	0.00196	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	8.83e-05	0.00194	CbGpPWpGaD
Debrisoquin—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	8.77e-05	0.00193	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.71e-05	0.00192	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	7.58e-05	0.00167	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.32e-05	0.00161	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.29e-05	0.0016	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	7.27e-05	0.0016	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.27e-05	0.0016	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.22e-05	0.00159	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.19e-05	0.00158	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	6.95e-05	0.00153	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	6.94e-05	0.00153	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	6.93e-05	0.00152	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	6.84e-05	0.0015	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.7e-05	0.00147	CbGpPWpGaD
Debrisoquin—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	6.69e-05	0.00147	CbGpPWpGaD
Debrisoquin—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	6.6e-05	0.00145	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.32e-05	0.00139	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—MCCC1—Parkinson's disease	6.31e-05	0.00139	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—ND3—Parkinson's disease	6.31e-05	0.00139	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.07e-05	0.00134	CbGpPWpGaD
Debrisoquin—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.07e-05	0.00133	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—TALDO1—Parkinson's disease	5.93e-05	0.0013	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—OMD—Parkinson's disease	5.93e-05	0.0013	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	5.62e-05	0.00124	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GCH1—Parkinson's disease	5.36e-05	0.00118	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.09e-05	0.00112	CbGpPWpGaD
Debrisoquin—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.04e-05	0.00111	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.04e-05	0.00111	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—ND3—Parkinson's disease	5.04e-05	0.00111	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.84e-05	0.00106	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GBA—Parkinson's disease	4.78e-05	0.00105	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—DBH—Parkinson's disease	4.78e-05	0.00105	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—FBP1—Parkinson's disease	4.78e-05	0.00105	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.75e-05	0.00104	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—ND3—Parkinson's disease	4.75e-05	0.00104	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—TALDO1—Parkinson's disease	4.74e-05	0.00104	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—OMD—Parkinson's disease	4.74e-05	0.00104	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.68e-05	0.00103	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.49e-05	0.000987	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.46e-05	0.000981	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—OMD—Parkinson's disease	4.46e-05	0.000981	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GCH1—Parkinson's disease	4.28e-05	0.000942	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.23e-05	0.00093	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.04e-05	0.000888	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GBA—Parkinson's disease	3.82e-05	0.000839	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—DBH—Parkinson's disease	3.82e-05	0.000839	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—FBP1—Parkinson's disease	3.82e-05	0.000839	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GBA—Parkinson's disease	3.6e-05	0.000791	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.6e-05	0.000791	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—DBH—Parkinson's disease	3.6e-05	0.000791	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—DDC—Parkinson's disease	3.51e-05	0.000771	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.42e-05	0.000752	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.34e-05	0.000734	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTA4—Parkinson's disease	3.31e-05	0.000729	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.27e-05	0.000719	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.2e-05	0.000704	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.14e-05	0.000691	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	2.98e-05	0.000656	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—MAOB—Parkinson's disease	2.95e-05	0.000649	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.81e-05	0.000618	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—DDC—Parkinson's disease	2.8e-05	0.000616	CbGpPWpGaD
Debrisoquin—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.78e-05	0.000612	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.65e-05	0.000582	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—DDC—Parkinson's disease	2.64e-05	0.000581	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.49e-05	0.000548	CbGpPWpGaD
Debrisoquin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.49e-05	0.000547	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.38e-05	0.000524	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—MAOB—Parkinson's disease	2.36e-05	0.000519	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.25e-05	0.000494	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.22e-05	0.000489	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	2.19e-05	0.000483	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CTGF—Parkinson's disease	2.15e-05	0.000474	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	2.01e-05	0.000441	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—NQO1—Parkinson's disease	1.98e-05	0.000436	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—TH—Parkinson's disease	1.96e-05	0.00043	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—CYCS—Parkinson's disease	1.88e-05	0.000413	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.75e-05	0.000385	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CTGF—Parkinson's disease	1.72e-05	0.000378	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—COMT—Parkinson's disease	1.66e-05	0.000366	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTP1—Parkinson's disease	1.66e-05	0.000364	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—MAOA—Parkinson's disease	1.65e-05	0.000363	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—HMOX1—Parkinson's disease	1.63e-05	0.000359	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.62e-05	0.000357	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.6e-05	0.000353	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—NQO1—Parkinson's disease	1.59e-05	0.000349	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—ABCB1—Parkinson's disease	1.57e-05	0.000345	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—TH—Parkinson's disease	1.56e-05	0.000344	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GSTM1—Parkinson's disease	1.52e-05	0.000335	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.51e-05	0.000332	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—CYCS—Parkinson's disease	1.5e-05	0.00033	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.49e-05	0.000328	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—TH—Parkinson's disease	1.47e-05	0.000324	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—GPX1—Parkinson's disease	1.46e-05	0.00032	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.41e-05	0.000311	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—MTHFR—Parkinson's disease	1.34e-05	0.000296	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000292	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.32e-05	0.000291	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.00029	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.3e-05	0.000287	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—COMT—Parkinson's disease	1.25e-05	0.000275	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—APOE—Parkinson's disease	1.25e-05	0.000275	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.25e-05	0.000274	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.24e-05	0.000273	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.23e-05	0.00027	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.21e-05	0.000267	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.18e-05	0.000259	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—GPX1—Parkinson's disease	1.16e-05	0.000256	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.14e-05	0.000252	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.1e-05	0.000241	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.07e-05	0.000236	CbGpPWpGaD
Debrisoquin—CYP1A1—Metabolism—INS—Parkinson's disease	1.07e-05	0.000235	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.01e-05	0.000223	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—APOE—Parkinson's disease	1e-05	0.00022	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—APOE—Parkinson's disease	9.42e-06	0.000207	CbGpPWpGaD
Debrisoquin—ABCB1—Metabolism—INS—Parkinson's disease	8.54e-06	0.000188	CbGpPWpGaD
Debrisoquin—CYP2D6—Metabolism—INS—Parkinson's disease	8.05e-06	0.000177	CbGpPWpGaD
